OrgHarvest, Inc.

OrgHarvest, Inc.

ORGH
OrgHarvest, Inc.US flagOther OTC
0.00
USD
- -
- -
4,917.00Market Cap
OrgHarvest, Inc.
ORGH
(Other OTC)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available
Business
OrgHarvest, Inc. (ORGH) operates as a development-stage company primarily focused on the recreational and medicinal cannabis industry; it cultivates, produces, extracts, and markets organic cannabis and cannabis-related products for retail marijuana stores, manufacturing facilities, and other cultivators. The company offers high-quality cannabis plants and biopharmaceutical products derived from organic cultivation processes. Founded in 1997 and headquartered in Camden, Delaware, with operational focus in Nevada including Las Vegas and Reno, OrgHarvest previously pursued cannabis greenhouse development through a $10 million deal and became the first cannabis cultivation firm to secure Regulation A approval from the U.S. Securities and Exchange Commission. In recent strategic shifts, OrgHarvest intends to launch a television network named Viva Telecompras for selling gemstones and jewelry, vitamins, and beauty care products sourced from third-party wholesalers, marking a pivot from its core cannabis operations to specialty retail. The company was subject to an all-stock acquisition of controlling interest by First Seed Farms, Inc., alongside patent licenses for rhamnolipid liposomes to combat diseases in cannabis and hemp plants.